Abstract Practice of a motor task leads to an increase in amplitude of motor-evoked potentials (MEP) in the exercised muscle. This is termed practice-dependent plasticity, and is abolished by the NMDA antagonist dextromethorphan and the GABA A agonist lorazepam. Here, we sought to determine whether speciWc subtypes of GABA A circuits are responsible for this eVect by comparing the action of the non-selective agonist, lorazepam with that of the selective GABA A -alpha 1 receptor agonist, zolpidem. In seven healthy subjects, transcranial magnetic stimulation (TMS) was used to quantify changes in amplitude of MEP after practice of a ballistic motor task. In addition we measured how the same drugs aVected MEP amplitudes and the excitability of a number of cortical inhibitory circuits [short-interval intracortical inhibition (SICI), short-interval aVerent inhibition (SAI) and long-interval intracortical inhibition]. This allowed us to explore correlations between drugs eVects in measures of cortical excitability and practice-dependent plasticity of MEP amplitudes. As previously reported, lorazepam increased SICI and decreased SAI, while zolpidem only decreased SAI. The new Wndings were that practicedependent plasticity of MEPs was impaired by lorazepam but not zolpidem, and that this was negatively correlated with lorazepam-induced changes in SICI but not SAI. This suggests that the intracortical circuits involved in SICI (and not neurons expressing GABA A -alpha 1 receptor subunits that are implicated in SAI) may be involved in controlling the amount of practice-dependent MEP plasticity.
Introduction
Pharmacological interventions coupled with transcranial magnetic stimulation (TMS) methods have made it possible to study a number of inhibitory circuits in the human cerebral cortex and to test how they are involved in particular types of motor behaviour. The present paper focuses on the role of subtypes of the GABA A receptor in synaptic plasticity induced when subjects learn a new motor task. ButeWsch et al. (2000) initially showed that if subjects practise an isolated thumb movement in a particular direction then the amplitude of motor-evoked potentials (MEP) evoked in agonist muscles is larger after practice than before. Since this was blocked by NMDA receptor antagonists, it was presumed to involve LTP-like changes in the eYcacy of glutamatergic synapses in motor cortex. The authors also found that the eVect was blocked by pretreatment with lorazepam, a non-selective GABA A agonist. The latter was compatible with reports in the animal literature that emphasised the role of GABA in regulating motor cortical plasticity (Hess et al. 1996) as well as with other investigations of synaptic plasticity in humans (Ziemann et al. 1998a Pleger et al. 2003) . Taken together these results suggest that LTP-like plasticity is enhanced when GABA inhibition is reduced. However, there is no information on whether speciWc subtypes of receptor are preferentially involved in the eVect.
The present experiments examined this question by comparing the eVects on practice-dependent synaptic plasticity of the non-selective GABA A agonist lorazepam with the selective GABA A -alpha 1 receptor agonist, zolpidem. We predicted that as both drugs are GABA agonists then both of them might potentially interfere with plasticity. However, if the GABA A -alpha 1 receptor were not involved then plasticity would be reduced only by lorazepam whereas it would be unaVected by zolpidem.
Simultaneously to this experiment, we also asked which neural circuits might be most involved in controlling levels of synaptic plasticity. A number of inhibitory intracortical circuits have been identiWed using TMS: short-interval intracortical inhibition (SICI), short-interval aVerent inhibition (SAI) and long-interval intracortical inhibition (LICI) (Kujirai et al. 1993; Wassermann et al. 1996; Tokimura et al. 2000; Sailer et al. 2002) . SICI is believed to involve GABA A receptor neurotransmission (Ziemann 2004; Florian et al. 2008) and LICI is believed to involve GABA B receptor neurotransmission (McDonnell et al. 2006; Florian et al. 2008) . Studies with the drug zolpidem indicate that the GABA A -alpha 1 receptor is associated with the pathway mediating SAI but not with that mediating SICI (Di Lazzaro et al. 2006 Lazzaro et al. , 2007 . We argued that if particular pathways are responsible for controlling plasticity then changes in the amount of plasticity produced by lorazepam or zolpidem would correlate with their eVects on SICI, LICI or SAI.
Methods

Study design
The study was structured as a double-blind randomised controlled cross-over trial with two drug arms. 2.5 mg lorazepam or 10 mg zolpidem was prepared by the pharmacy of the National Hospital for Neurology and Neurosurgery into unmarked containers. A placebo arm would be easily unblinded and would also not control for the eVects of sedation so no placebo arm was used. Subjects had TMS measurements at three time points: T 1 , T 2 and T 3 . The allocated drug was given at the end of T 1 . TMS measurements at T 2 occur 2 h after drug ingestion coinciding with the peak plasma concentration of lorazepam and zolpidem: lorazepam, 1.5-2.5 h (Kyriakopoulos et al. 1978) ; zolpidem, 0.75-2.6 h (Salva and Costa 1995) . After T 2 , subjects performed the motor practice task (see below) and after completion of the task, proceeded to have TMS measurements again at T 3 . The study design is summarised in Fig. 1 .
For the subjects' second session, they received the other drug. The order was randomised and balanced (4 subjects Fig. 1 Study design. a Timeline of a single experimental session with three timepoints: T 1 , T 2 and T 3 , corresponding to baseline, during drug peak levels and after task practice; b multiple neurophysiological measurements were made during each timepoint; and c task practice consisted of 15 paced thumb abduction movements repeated over 10 blocks with frequent rest breaks received lorazepam in the Wrst session). The inter-session interval was 27.7 days (range 10-50 days).
Subjects
Seven healthy subjects were recruited and informed written consent was obtained [age = 30.3 § 3.8 years (SD), 1 female]. All subjects were right-handed (not formally measured) and were not on any medication. The experiments conformed to the Declaration of Helsinki and were carried out with approval of the local Ethics Committee.
Transcranial magnetic stimulation
Surface EMG was recorded from the left abductor pollicis brevis (APB) muscles, the left Wrst dorsal interossei (FDI) and the left Xexor carpi radialis (FCR) with Ag/AgCl electrodes using a tendon-belly montage. EMG signals were ampliWed with Digitimer D360 ampliWers (Digitimer, Welwyn Garden City, UK) with 1000£ gain and band-pass Wltered (30-1,000 Hz for MEP) and sampled at 5 kHz using a CED1401 laboratory interface and Signal software (Cambridge Electronic Design, Cambridge, UK).
Magnetic stimuli were delivered with two Magstim-200 magnetic stimulator (The Magstim Co., Whitland, UK) connected by a Y-cable. A Wgure-of-8 coil (diameter 80 mm) was adjusted over the optimal scalp position to evoke an MEP in the right APB with the coil handle pointed posterolaterally at a 45° angle to the sagittal plane. The resting motor threshold (RMT) was deWned as the lowest intensity capable of inducing at least 5 out of 10 MEPs of >50 V peak-to-peak amplitude. The active motor threshold (AMT) was deWned as the lowest intensity capable of inducing at least 5 out of 10 MEPs of >200 V peak-to-peak amplitude during an active tonic contraction of thumb APB.
The settings for the various TMS measures are as follows:
1. The corticospinal excitability was measured at rest at 150% RMT over 10 trials. 2. SICI and intracortical facilitation (ICF) were measured with the test MEP amplitude set at »1-mV and the conditioning stimulus set at 80% AMT or 100% AMT. The interstimulus interval was 3 ms (for SICI), 8 ms and 15 ms (for ICF). Ten trials were recorded for each condition and the test condition. 3. LICI was measured with the test MEP amplitude set at »1-mV and the conditioning stimulus set at 110% RMT or 120% RMT. The interstimulus interval was 100 ms (for LICI). Ten trials were recorded for each condition and the test condition. 4. Short-latency aVerent inhibition (SAI) and longlatency aVerent inhibition (LAI) were measured with the test MEP amplitude set at »1-mV. Electrical stimulation (200 s pulse width) was delivered to the median nerve using a Digitimer DS7A Constant Current Stimulator (Digitimer, Welwyn Garden City, Herts, UK) at twice or thrice sensory threshold. The interstimulus interval was 22 ms (for SAI) and 100 ms (for LAI). Ten trials were recorded for each condition and the test condition.
The order of the various TMS measurements were randomised (Fig. 1b) . In addition to the TMS measurements, all subjects Wlled a visual analogue scale (VAS) of arousal before and after each time point. The visual analogue scale was a 24 cm horizontal line with the left extreme marked 'Wide awake' and the right extreme marked 'Fast asleep'.
Motor practice
The motor task consists of a paced ballistic thumb abduction task similar to that used in previous studies (Muellbacher et al. 2002) . This motor task has been demonstrated to be dependent on the primary motor cortex, is associated with changes in MEP amplitude and movement representation (Classen et al. 1998; Muellbacher et al. 2001) and can be disrupted in the Wrst hour after motor practice (Muellbacher et al. 2002) . In this study, the subject's left forearm, hand and Wngers were secured in a wooden frame leaving the thumb free to abduct in the horizontal plane. A piezoresistive monoaxial accelerometer (Model SA-105 vibrometer, Fribourg, Switzerland) was attached on the lateral aspect of the left thumb proximal phalanx with the maximal vector being thumb abduction. The accelerometer signal was sampled at 5,000 Hz and not Wltered.
The task consisted of paced ballistic thumb abduction to a loud auditory tone played at 0.333 Hz. 15 thumb abductions were performed per block for 10 blocks, with a 15-s rest break between blocks (Fig. 1c) . If the subjects missed any movement, they were required to perform a 'replacement movement'. In total, subjects practiced 150 movements for 10 min. Subjects were motivated with verbal encouragement by a blinded investigator. Visual feedback of the acceleration from the previous trial was provided on a computer screen to the subject and the subject was told to attend to the feedback on the computer screen not to their hand as subjective judgement of thumb acceleration is often inaccurate.
Data analysis
Peak-to-peak amplitude of MEP was used as the primary measure of corticospinal recruitment. The other intracortical measures are represented as follows:
1. SICI and ICF were represented as peak-to-peak amplitude of conditioned stimulus normalised to test stimulus. 2. LICI was represented as peak-to-peak amplitude of conditioned stimulus normalised to test stimulus. 3. SAI and LAI was represented as peak-to-peak amplitude of conditioned stimulus normalised to test stimulus. The values for 2£ and 3£ sensory threshold stimulation were averaged and represented as a single value as there was no evidence of interaction.
Blinding was conducted by an independent researcher and all data analysis was conducted by a blinded researcher.
Statistical analysis
Statistical analysis was performed using SPSS 12.0 software (SPSS, SPSS Inc). To compare the eVects of drug arms in the various intracortical measures, repeated-measures analysis of variation (ANOVA) was used; the various factors used in the ANOVAs are described in the text. The threshold for statistical signiWcance ( ) was set at p < 0.05.
Results
Subjects correctly identiWed the drug taken on 6 out of 14 sessions (42.9%) which is not above chance (two-tailed Fisher's exact test, p > 0.05). The RMT, AMT, sensory threshold and conditioning stimulus intensities at baseline, after drug ingestion and after practice are shown in Tables 1, 2 and 3, respectively. There were no statistically signiWcant diVerences in RMT, AMT, sensory threshold or test stimulus amplitude between the drug arms.
Drug-induced changes in cortical circuits
As previously reported (Di Lazzaro et al. 2006) , lorazepam increased SICI, while zolpidem did not aVect SICI (Fig. 2) . The diVerence in eVect on SICI of lorazepam and zolpidem was statistically signiWcant on three-factorial ANOVA (within-subject factors INTENSITY, TIME, DRUG) with an interaction of TIME £ DRUG (F (1,12) = 7.227, p = 0.020). Post hoc testing with Bonferroni correction showed a signiWcant diVerence between T 1 and T 2 for the lorazepam group (p = 0.002) but not in the zolpidem group (p = 0.802). Post hoc testing of the SICI at T 2 showed a signiWcant diVerence between the lorazepam and zolpidem arms (student's paired t test, p = 0.041). The reduction of SAI by both drugs was also statistically signiWcant as previously reported (Di Lazzaro et al. 2007 ). Three-factorial ANOVA (within-subject factors INTEN-SITY, TIME, DRUG) showed a signiWcant interaction of TIME £ DRUG (F (1,12) = 7.23, p = 0.02). Post hoc testing with Bonferroni correction showed a signiWcant diVerence between T 1 and T 2 for the lorazepam group (p = 0.018) and for the zolpidem group (p < 0.001), but no signiWcant diVerences between the two drugs at T 1 (p = 0.539). Post hoc testing of the SAI at T 2 did not show any signiWcant diVerence between the lorazepam and zolpidem arms (student's paired t test, p = 0.118).
The eVect of the drugs on MEP amplitudes at 150% RMT was not signiWcant (p > 0.05 in both drug arms). Likewise, there was no signiWcant eVect on LICI at 110% RMT and 120% RMT (supplementary Fig. 1 ). There was no signiWcant drug-induced eVect on other intracortical circuits (ICF and LAI) and data are enclosed as supplementary material.
All subjects experienced lethargy after ingestion of the drug. Their responses on the visual analogue scale for sedation (before zolpidem 3.7 cm § 3.3 SD, after zolpidem 10.4 cm § 4.9 SD; before lorazepam 3.4 cm § 3.3 SD, after lorazepam 10.6 cm § 5.6 SD, student's paired t test p < 0.01) were not signiWcantly diVerent after drug ingestion between drug arms (student's paired t test p = 0.91).
Performance during motor practice
All subjects completed 10 blocks of 15 movements training. Peak acceleration during the 10 min is shown in Fig. 3 . On a two-factorial ANOVA of DRUG £ BLOCK, there was an eVect of BLOCK (F (1,9) = 2.94, p = 0.004) indicating a progressively stronger initial peak acceleration of thumb abduction despite sedation. There appeared to be a fatiguing eVect in the zolpidem group after block 7-10 but there were no signiWcant diVerences between drug sessions (F (1,12) = 0.583, p = 0.460) and there was also no signiWcant interaction of DRUG x BLOCK (F (1,9) = 0.868, p = 0.447).
Practice-induced changes in MEP
The MEP changes after practice are shown in Fig. 4a, b. A three-factorial repeated-measures ANOVA was performed In summary after zolpidem, MEP amplitude in the APB muscle increased after task practice, while after lorazepam, there was no increase after task practice.
Correlation of drug-induced change in SICI and SAI with eVects on practice-induced plasticity of MEPs
The change of SICI from T 1 to T 2 for the lorazepam sessions (i.e. lorazepam-induced SICI change) was signiWcantly, and negatively, correlated with the change of MEP amplitude from T 2 to T 3 (Spearman's rank correlation, = ¡0.86, p = 0.01). Thus, subjects who showed the largest increases in SICI had the smallest changes in MEP amplitude after motor practice. The change of SAI from T 1 to T 2 (i.e. drug-induced SAI change) was not correlated with the diVerence of MEP amplitude from T 2 to T 3 (Spearman's rank correlation, = ¡0.04, p = 0.94 for lorazepam sessions and Spearman's rank correlation, = 0.07, p = 0.88 for zolpidem sessions). This correlation can be seen on Fig. 5 where positive values of SICI on the right represent stronger inhibition while negative values of SAI on the left represent weaker inhibition. Surprisingly, there was also a tendency for drug-induced SAI change to correlate with drug-induced change in the visual analogue scale for the level of sedation (Spearman's rank correlation, = ¡0.529, p = 0.052). There is no correlation between performance in the task practice and the amount of MEP increase (Spearman's rank correlation, p = 0.34 for the zolpidem arm of the experiment).
Discussion
In summary, this study conWrms previous reports that nonspeciWc enhancement of GABA A transmission with lorazepam blocks practice-induced MEP plasticity (ButeWsch et al. 2000; Ziemann et al. 2001 ) and that the selective GABA A -alpha 1 receptor agonist, zolpidem reduces SAI but has no eVect on SICI (Di Lazzaro et al. 2007) . Our novel Wnding is that zolpidem does not aVect practice-induced MEP plasticity. Together the data imply that the SAI circuit is not an important controller of practice-induced MEP plasticity. In contrast, the inhibition of practice-induced MEP plasticity by lorazepam correlates with the increase of SICI induced by lorazepam. This suggests that the circuits involving SICI may be important controllers of practiceinduced MEP plasticity.
Drug-induced changes in cortical circuits
Our results showing a lack of eVect of zolpidem on SICI conWrm a previous study (Di Lazzaro et al. 2006) . In both studies, the dose of zolpidem was similar, and was calculated to be speciWc to the GABA A -alpha 1 receptor (Mohler et al. 2002 (Mohler et al. , 2005 ). The conclusion is that the eVect of lorazepam on SICI is not due to activation of GABA A -alpha 1 Fig. 4 The eVect of training on the (a) corticospinal excitability in the trained abductor pollicis brevis (APB) muscle and (b) in an untrained hand muscle, the abductor digiti minimi (ADM) muscle. In all cases, the unWlled bars represent the lorazepam sessions and the Wlled bars represent the zolpidem sessions. Comparisons were by post hoc student's paired t tests with ** represents p < 0.01 and ns represents p > 0.05 
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receptors. As previously noted (Di Lazzaro et al. 2007) , the speciWcity of the eVect on SICI contrasts with that of the SAI circuit which was aVected by both lorazepam and zolpidem. The lack of eVect on MEP amplitude by lorazepam in this study compared to previous studies Kimiskidis et al. 2006) can be explained by the low intensity used to assess corticospinal excitability (»60% MSO) compared to previous studies (>65% MSO in Kimiskidis et al. 2006) . Additionally, Kimiskidis et al. 2006 also found an eVect on cortical silent period (a measure considered analogous to LICI) at higher intensities. Again, higher intensities were not assessed in this current study, so no conclusions can be made about these inhibitory circuits or GABA B receptors.
Practice-dependent MEP plasticity
This study conWrms previous reports that this practicedependent plasticity is blocked by the GABA agonist lorazepam (ButeWsch et al. 2000) . Such eVects have direct parallels in the animal literature. Direct recordings in the primary motor cortex of rats after motor training suggest that motor training is associated with LTP of the excitatory synapses onto pyramidal neurons in layer II/III of the primary motor cortex (Rioult-Pedotti et al. 1998 . In addition, induction of LTP in the same synapses by direct electrical stimulation requires GABA activity to be reduced by prior administration of an antagonist, bicuculline (Hess et al. 1996) . Thus, it may be that the enhancement of GABA-ergic activity in humans by lorazepam is the principal cause of the reduction in practice-dependent plasticity (ButeWsch et al. 2000) .
This conclusion is strengthened by the new data reported here showing that the subjects in whom lorazepam increased SICI were less likely to show practice-dependent plasticity of MEPs than those in whom the drug-induced eVects on SICI were weak. The fact that zolpidem had little eVect on SICI and little eVect on plasticity may even indicate that the inhibitory connections activated during the SICI paradigm are a primary controller of practice-dependent MEP changes. In contrast the inhibitory eVects produced by the SAI circuit may be much less relevant, since the changes in SAI were not correlated with changes in plasticity. It would also be consistent with the fact that administration of scopolamine, a muscarinic antagonist that reduces SAI also reduces (rather than increases) practice-dependent plasticity (Sawaki et al. 2002) . Since scopolamine does not aVect SICI, its inXuence on learning is probably via a diVerent mechanism to the GABA-related eVects discussed here.
One important drawback of this study is the inability to use a true placebo due to the behavioural eVects of these two sedative drugs. Without the placebo arm, it is not possible to quantify precisely how much of the inhibition of practice-dependent plasticity is related to drowsiness and how much is related to GABA-ergic agonism as plasticity is known to be aVected by attention (Stefan et al. 2004) . Additionally, without a placebo arm, it is not possible to conclusively state that there is no role to play for GABA Aalpha 1 receptors or SAI in practice-dependent plasticity as there might still be a smaller degree of inhibition of practice-dependent plasticity. Nonetheless, it is possible to conclude that there is a diVerence in degree if inhibition of practice-dependent plasticity between SICI and SAI. It is interesting to note that although there was no signiWcant MEP enhancement in the lorazepam arm of the experiment after practice, there was clear improving motor performance during the practice. Thus, additional factors or mechanisms beyond practice-dependent plasticity of MEPs are likely to be playing a role in the performance improvement in the lorazepam arm.
Although this study has shown an association for SICI in practice-dependent plasticity like previous studies (Ziemann et al. 1998a, b; Ziemann et al. 2002) , it is also possible that the correlation between the practice-dependent plasticity and the drug-induced eVect on SICI may not necessarily be causally linked as lorazepam may be enhancing GABA-ergic signalling in other independent circuits which have yet to be identiWed and it is these circuits that are predominantly inhibiting practice-dependent plasticity. This remains a possibility although a less parsimonious one.
Finally, why is it that increasing GABA-ergic signalling in the SICI pathway aVects practice-dependent plasticity to a greater degree than SAI? Any inhibition should reduce excitability in the cortex, and make it more diYcult to produce LTP (Hess et al. 1996; Glazewski et al. 1998; Steele and Mauk 1999; Casasola et al. 2004 ). However, inhibitory synapses have diVerent eVects depending on the spatial localisation of the synapses on the pyramidal cell with inhibitory synapses to the perisomatic region being more potent but less selective than inhibitory synapses to the distal dendrites (Miles et al. 1996; Segev and Burke 1998; Markram et al. 2004 ). The predominant expression of zolpidem-sensitive GABA receptors to the perisomatic region of pyramidal cells (Klausberger et al. 2002; Xiang et al. 2002; Bacci et al. 2003 ) and zolpidem-insensitive GABA receptors to the distal dendrites (Ali and Thomson 2008) suggest that SICI and SAI may synapse at diVerent locations on the pyramidal cell and thus modulate practicedependent plasticity to diVering degrees.
As muscarinic receptor antagonists also aVect SAI (Di , SAI inhibitory interneurons may be similar to fast-spiking basket cells described in animal studies which also express GABA A -alpha 1 receptor and muscarinic acetylcholine receptors and synapse onto the perisomatic region of the pyramidal cell (Nusser et al. 1996; Kawaguchi and Kubota 1997; Fritschy et al. 1998; Xiang et al. 1998; Kubota and Kawaguchi 2000; Klausberger et al. 2002; Kawaguchi et al. 2006; Ali and Thomson 2008; Ascoli et al. 2008) and thus the perisomatic inhibition by SAI may be less relevant to practice-dependent plasticity which predominantly occurs in layer II/III synapses in the pyramidal dendrites (Rioult-Pedotti et al. 1998 . Thus, the similarities between SAI and inhibition by fast-spiking basket cells are suggestive, but this still remains unproven.
Conclusion
In summary, we demonstrate that practice-dependent plasticity of MEPs is limited to diVering degrees by diVerent GABA-ergic intracortical circuits. The use of GABA-subunit selective drugs allows for dissection of the physiological functions of various inhibitory intracortical circuits.
